Basaglar (insulin glargine) is a long-acting insulin. It's used to manage blood sugar levels in adults and children with Type 1 diabetes or Type 2 diabetes. Basaglar (insulin glargine) is given as an injection under the skin once per day. Your healthcare team will determine your dose based on different things, such as your diet and your blood sugar levels. This medication comes as a pre-filled pen called Basaglar KwikPen, as well as a smart insulin pen called Basaglar Tempo Pen that can connect to a smartphone. Some side effects of this medication include low blood sugar levels and pain or swelling at the injection site.
Basaglar (insulin glargine) is an insulin. Insulin is a natural hormone your body makes to control blood sugar levels. It helps your body absorb and store sugar from the bloodstream after a meal. Insulin also stops your liver from making glucose (sugar). But people with diabetes can't make insulin, don't make enough insulin, or their body doesn't respond to insulin as it should.
Basaglar (insulin glargine) is a long-acting insulin. It helps control blood sugar levels throughout the day. Basaglar (insulin glargine) is used by people who don't make insulin or need more insulin than what their body can produce.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
How to inject Basaglar (insulin glargine):
Basaglar (insulin glargine) is a long-acting insulin. It's typically injected under the skin once daily. Each dose can help manage blood sugar levels all day. Depending on what type of diabetes you have, your healthcare team might also prescribe a fast-acting insulin (e.g., insulin aspart (Novolog) or insulin lispro (Humalog)) to help you manage blood sugar levels after meals.
Basaglar (insulin glargine) starts to lower your blood sugar levels about 2 to 4 hours after a dose. The effects of each dose last for about 24 hours.
Yes, it's possible to gain weight from Basaglar (insulin glargine). The reason for this is because insulin tells your cells to take up sugar from the blood in order to lower blood sugar levels. The sugar in cells is then converted into fat. Over time, this can lead to weight gain. To lower your risk for weight gain, your healthcare team can help you plan a nutritious diet that's low in sugar and a regular exercise routine that works best for you. Talk with your healthcare team if you have more questions about the risk of weight gain from Basaglar (insulin glargine).
Basaglar (insulin glargine) isn't typically injected twice per day because it's a long-acting insulin that lowers your blood sugar for up to 24 hours after a dose. But studies suggest some people might benefit from twice-daily insulin glargine if the once-daily injections aren't enough to control their blood sugar levels. Make sure to take Basaglar (insulin glargine) exactly as prescribed. Contact your healthcare team if you have questions about how often you should receive your dose.
Lantus (insulin glargine) and Basaglar (insulin glargine) aren't exactly the same, but they're very similar. Both are long-acting insulins that contain insulin glargine as the active medication. But Basaglar and Lantus are made in slightly different ways. Because of this, some people might think of Basaglar as a biosimilar to Lantus. But Basaglar hasn't been officially approved as a biosimilar to Lantus. Both Basaglar and Lantus work similarly well in controlling blood sugar levels. But there aren't any studies looking at whether you can switch between the two medications, so Basaglar isn't considered interchangeable with Lantus. Talk with your diabetes care team if you have specific questions about either medication.
Semglee and Basaglar are both brand names containing insulin glargine. Both medications are injected under the skin once daily to help manage blood sugar levels throughout the day. The main difference between them is that Semglee a interchangeable biosimilar to Lantus, but Basaglar isn't. This means that if your healthcare team prescribes Semglee and it's not available at the pharmacy, the pharmacist can substitute it with Lantus, but not Basaglar. Talk to your endocrinologist if you have specific questions about the differences between Semglee and Basaglar.
Both Basaglar (insulin glargine) and Tresiba (insulin degludec) are insulins that can control blood sugar levels throughout the day. One difference between them is how long they last. Basaglar works for about 24 hours after a dose, while Tresiba works for up to 42 hours. Another difference is storage. Tresiba can be stored for 56 days after opening, whereas Basaglar can be stored for 28 days. A third difference is concentration. Both insulins come as 100 units/mL of insulin, but only Tresiba comes as a more concentrated form containing 200 units/mL of insulin. Talk to your healthcare team if you have questions on the differences between both brand names.
It's best to store unopened Basaglar (insulin glargine) pens in the refrigerator because it can be kept up until the manufacturer's expiration date written on the pen. But, if you store them at room temperature, they're only good for 28 days (4 weeks). Opened Basaglar (insulin glargine) pens should be stored only at room temperature for up to 28 days.
Basaglar (insulin glargine) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Never share Basaglar (insulin glargine) pens, syringes, or needles with anyone else. Sharing Basaglar (insulin glargine) puts you and the person who's also using the same pen at risk of getting very dangerous infections and health conditions.
Changing your insulin or insulin routine, such as where you inject Basaglar (insulin glargine), can affect how your body responds to insulin. This can lead to either high or low blood sugar levels. In addition, injecting Basaglar (insulin glargine) repeatedly into skin areas that shows signs of lipodystrophy, such as pitting or thickened skin, can also result in high blood sugar levels.
Don't make changes to your Basaglar (insulin glargine) dose or routine without first checking in with your diabetes care team. Make sure to avoid injecting into skin areas that show signs of lipodystrophy. If your care team instructs you to make any changes to your insulin routine, they'll also ask you to check your blood sugar levels more often to see how the changes affect your blood sugar levels.
Using Basaglar (insulin glargine) alone or together with other medications that lower blood sugar can lead to hypoglycemia, which is dangerously low blood sugar levels. If not treated in time, it can be life-threatening.
Check your blood sugar level regularly to make sure it's within a safe range. If your diabetes care team instructs you to mix different insulins together, read the label of the insulins carefully to make sure you're using the right products. But remember, Basaglar (insulin glargine) should never be mixed with other insulins in the same syringe. If you make any changes to your diet or meal patterns, other medications, or how much you exercise, let your care team know because they might need to adjust your dose of Basaglar (insulin glargine).
Make sure you're familiar with symptoms of hypoglycemia, such as feeling shaky, being nervous or anxious, sweating or body chills, and excessive hunger. Keep fast-acting sugars, such as glucose tablets, with you at all times so you can treat an episode of hypoglycemia. If your blood sugar levels don't improve even after you take fast-acting sugars, get medical help right away.
Basaglar (insulin glargine) can cause low potassium levels in your blood, which can be dangerous. You're at higher risk if you're already taking medications that can lower potassium levels, such as loop diuretics. Because people with low blood potassium levels typically don't experience any symptoms, your care team might order blood tests to check your potassium levels regularly. And if needed, they'll prescribe you medications to bring your potassium level within a safe range. Get medical help right away if you notice symptoms of low potassium levels such as weakness, muscle cramps or twitches, and constipation.
Taking Basaglar (insulin glargine) with glitazones (also known as thiazolidinediones), like pioglitazone (Actos), can cause your body to hold onto fluid. This can lead to or worsen heart failure because the additional fluid can put stress on your heart and cause symptoms such as trouble breathing or the inability to exercise.
Make sure to tell your diabetes care team if you have heart failure or if you're taking a glitazone before starting Basaglar (insulin glargine).
Rarely, Basaglar (insulin glargine) can cause a serious, life-threatening reaction (e.g., anaphylaxis). If you experience swelling in your lips, face, or tongue, rash, or trouble breathing, get medical help right away.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| five 3ml kwikpens of 100 units/ml | 1 carton | $261.53 | $261.53 |
| five 3ml tempo pens of 100 units/ml | 1 carton | $319.55 | $319.55 |
Your prescriber will work with you to find the dose that works best for you. Your dose depends on many things, such as whether you have Type 1 or Type 2 diabetes, your blood sugar levels, and your weight. You might need to use a fast-acting insulin along with Basaglar.
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Basaglar (insulin glargine) will not be safe for you to take.